Longevity Research
Longevity-focused peptide research has accelerated significantly in 2026, driven by a convergence of interests in telomere biology, mitochondrial function, and immune system optimization. Three compounds in particular have drawn outsized research attention: Epitalon for its studied effects on telomerase activation, MOTS-c for its role in mitochondrial signaling, and Thymosin Alpha-1 for its immunomodulatory pathway research. Each addresses aging biology through a distinct mechanism.
Epitalon (also written Epithalon) is a synthetic tetrapeptide — Ala-Glu-Asp-Gly — derived from Epithalamin, a polypeptide extract of the pineal gland originally studied by Russian scientist Vladimir Khavinson beginning in the 1980s. The compound has been studied for its effects on telomerase activity — the enzyme responsible for maintaining telomere length, which shortens with each cell division and is considered a molecular marker of cellular aging.
Research published in Eastern European literature — the largest body of Epitalon research exists in Russian scientific journals — has examined its effects on telomere elongation in human somatic cells in vitro, melatonin secretion regulation, and circadian rhythm modulation. Western research has begun engaging with this literature more seriously in recent years.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a peptide encoded within mitochondrial DNA — specifically the 12S rRNA gene — making it one of the few known mitochondrial-derived peptides. It was first identified in 2015 and has since become one of the more actively studied compounds in metabolic and longevity research.
Research has focused primarily on MOTS-c's role in AMPK pathway activation — a master energy sensor that regulates cellular metabolism — and its studied effects on insulin sensitivity in animal models. A 2019 study published in Nature Communications found that circulating MOTS-c levels decline with age in humans, and that exogenous MOTS-c administration in aged mice reversed multiple age-related metabolic changes. This finding has been central to the research interest in MOTS-c as a potential longevity compound.
Thymosin Alpha-1 is a 28-amino acid peptide naturally secreted by the thymus gland. The thymus — responsible for T-cell development and immune system maturation — atrophies progressively with age, and Thymosin Alpha-1 levels correspondingly decline. Research has examined whether exogenous Thymosin Alpha-1 can modulate T-cell signaling and dendritic cell function in aging immune systems.
Unlike many research peptides, Thymosin Alpha-1 has an FDA-approved pharmaceutical counterpart (Zadaxin) used outside the US for specific immunodeficiency and hepatitis B and C indications, providing a substantial clinical research foundation. In research settings, it is studied for T-cell differentiation pathway modeling, toll-like receptor signaling, and immune response optimization in aged animal models.
The combination addresses aging biology at three distinct but interconnected levels: telomere integrity (Epitalon), mitochondrial function (MOTS-c), and immune system optimization (Thymosin Alpha-1). Multi-pathway longevity research protocols frequently incorporate all three to study whether their mechanisms produce additive effects across different aging hallmarks simultaneously.
Plato Peptides carries Epitalon 10mg, MOTS-c 10mg, and Thymosin Alpha-1 in both 5mg and 10mg vials. All compounds ship with independent third-party COA documentation at ≥98% purity.